Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Not well established in human studies
Delivery
Subcutaneous or intramuscular injection
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Cortagen is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from brain cortex tissue that acts as a bioregulator with neuroprotective and immunomodulatory properties. Research indicates it influences gene expression, particularly in cardiovascular and neural tissues, while demonstrating effects on immune function and cellular aging processes. It belongs to a class of short peptides that work through epigenetic mechanisms to modulate tissue-specific function.
Research protocols typically involve subcutaneous or intramuscular administration. Dosing in experimental studies has ranged from micromolar concentrations in vitro to milligram quantities in animal models, administered over periods of 10-30 days. Timing and frequency vary by research objective, with some studies using daily administration while others employ less frequent dosing schedules.
Cortagen operates through epigenetic modification of chromatin structure, influencing gene expression without altering DNA sequences. It modulates IL-2 mRNA synthesis in hypothalamic structures and affects lymphocyte chromatin in aging subjects. Microarray analysis has shown it regulates multiple gene pathways in cardiac tissue. The peptide demonstrates antioxidant properties by influencing free-radical processes and provides neuroprotection during ischemic conditions, potentially through preconditioning mechanisms.
Cortagen is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from brain cortex tissue that acts as a bioregulator with neuroprotective and immunomodulatory properties. Research indicates it influences gene expression, particularly in cardiovascular and neural tissues, while demonstrating effects on immune function and cellular aging processes. It belongs to a class of short peptides that work through epigenetic mechanisms to modulate tissue-specific function.
Cortagen has an approximate half-life of Not well established in human studies. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
Cortagen is typically delivered via subcutaneous or intramuscular injection. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
Cortagen operates through epigenetic modification of chromatin structure, influencing gene expression without altering DNA sequences. It modulates IL-2 mRNA synthesis in hypothalamic structures and affects lymphocyte chromatin in aging subjects. Microarray analysis has shown it regulates multiple gene pathways in cardiac tissue. The peptide demonstrates antioxidant properties by influencing free-radical processes and provides neuroprotection during ischemic conditions, potentially through preconditioning mechanisms.
Studied benefits of Cortagen include: Neuroprotection during cerebral ischemia and chronic brain ischemia, Modulation of immune function through lymphocyte activation, Epigenetic regulation of gene expression in aging tissues, Reduction of oxidative stress and free-radical damage, Enhancement of IL-2 synthesis and immune signaling, Improvement of metabolic and functional parameters in ischemic brain tissue, Support of hemostasis and immune parameters in aging models. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of Cortagen include: Limited human safety data available, Potential injection site reactions, Unknown long-term effects in humans, Possible immunomodulatory effects requiring monitoring, Interactions with other peptide bioregulators not fully characterized. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other cognitive compounds in the Peptides Calculator library.
Half-life · Estimated 30-60 minutes (typical for short peptides)
Half-life · Unknown; estimated at 20-30 minutes in circulation
Half-life · 6-8 hours
Half-life · Approximately 30-60 minutes with C-terminal amidation providing enhanced stability
Half-life · 60-90 minutes
Half-life · Approximately 2-4 hours